Global Nausea And Vomiting Treatment Market Size By Segmentations, Top Key Players, Trend, Future Development & Forecast 2024-2035
- PUBLISHED ON
- 11/23/2022
- NO OF PAGES
- 248
- CATEGORY
- Healthcare & Life Sciences
The competitive landscape analysis of Nausea And Vomiting Treatment Market uncovers detailed company profiles, revenue shares, portfolio innovations, regional product footprint, key developmental strategies, pricing structure, target markets, and near-term plans of market leaders. This entire section helps readers gain an essence of what is driving competition and what would help them stand out to win new target markets.
Market estimates and forecast are backed by an extensive primary research, further complemented by on-point secondary research of Nausea And Vomiting Treatment Market. The research analysts have invested significant time and effort in gathering critical industry information from KIPs such as OEMs, top suppliers and distributors, and government bodies.
Market Segmentations:
Global Nausea And Vomiting Treatment Market: Top Key Players
Merck & Co. Inc.
Helsinn Group
Unimed Pharmaceuticals (AbbVie Inc.)
Kyowa Kirin
Sanofi
Qilu Pharma
Teva Pharmaceutical Industries Ltd.
Taiji group
Novartis
Heron Therapeutics
Atnahs Pharma UK Limited
Mylan
Duchesnay
Tesaro
Nausea And Vomiting Treatment Breakdown Data by Type
Serotonin Receptor Antagonist
Neurokinin NK1 Receptor Antagonist
Other
Serotonin receptor antagonist had the biggest market share of 61% in 2018.
Nausea And Vomiting Treatment Breakdown Data by Application
CINV
PONV
Motion Sickness
Pregnancy
Others
CINV is the greatest segment of Nausea And Vomiting Treatment application, with a share of 49% in 2018.
Global Nausea And Vomiting Treatment Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.
Reasons to Purchase Nausea And Vomiting Treatment Market Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Base Year: 2023Market estimates and forecast are backed by an extensive primary research, further complemented by on-point secondary research of Nausea And Vomiting Treatment Market. The research analysts have invested significant time and effort in gathering critical industry information from KIPs such as OEMs, top suppliers and distributors, and government bodies.
Market Segmentations:
Global Nausea And Vomiting Treatment Market: Top Key Players
Merck & Co. Inc.
Helsinn Group
Unimed Pharmaceuticals (AbbVie Inc.)
Kyowa Kirin
Sanofi
Qilu Pharma
Teva Pharmaceutical Industries Ltd.
Taiji group
Novartis
Heron Therapeutics
Atnahs Pharma UK Limited
Mylan
Duchesnay
Tesaro
Nausea And Vomiting Treatment Breakdown Data by Type
Serotonin Receptor Antagonist
Neurokinin NK1 Receptor Antagonist
Other
Serotonin receptor antagonist had the biggest market share of 61% in 2018.
Nausea And Vomiting Treatment Breakdown Data by Application
CINV
PONV
Motion Sickness
Pregnancy
Others
CINV is the greatest segment of Nausea And Vomiting Treatment application, with a share of 49% in 2018.
Global Nausea And Vomiting Treatment Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.
Reasons to Purchase Nausea And Vomiting Treatment Market Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Historic Year: 2016-2022
Forecast: 2024-2035
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nausea And Vomiting Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Nausea And Vomiting Treatment Market Size Growth Rate by Type: 2022 VS 2030
1.4.2 Serotonin Receptor Antagonist
1.4.3 Neurokinin NK1 Receptor Antagonist
1.4.4 Other
1.5 Market by Application
1.5.1 Global Nausea And Vomiting Treatment Market Share by Application: 2022 VS 2030
1.5.2 CINV
1.5.3 PONV
1.5.4 Motion Sickness
1.5.5 Pregnancy
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Nausea And Vomiting Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Nausea And Vomiting Treatment Industry
1.6.1.1 Nausea And Vomiting Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Nausea And Vomiting Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Nausea And Vomiting Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Nausea And Vomiting Treatment Market Perspective (2016-2030)
2.2 Nausea And Vomiting Treatment Growth Trends by Regions
2.2.1 Nausea And Vomiting Treatment Market Size by Regions: 2016 VS 2022 VS 2030
2.2.2 Nausea And Vomiting Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Nausea And Vomiting Treatment Forecasted Market Size by Regions (2022-2030)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Nausea And Vomiting Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Nausea And Vomiting Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Nausea And Vomiting Treatment Players by Market Size
3.1.1 Global Top Nausea And Vomiting Treatment Players by Revenue (2016-2021)
3.1.2 Global Nausea And Vomiting Treatment Revenue Market Share by Players (2016-2021)
3.1.3 Global Nausea And Vomiting Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Nausea And Vomiting Treatment Market Concentration Ratio
3.2.1 Global Nausea And Vomiting Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Nausea And Vomiting Treatment Revenue in 2021
3.3 Nausea And Vomiting Treatment Key Players Head office and Area Served
3.4 Key Players Nausea And Vomiting Treatment Product Solution and Service
3.5 Date of Enter into Nausea And Vomiting Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2030)
4.1 Global Nausea And Vomiting Treatment Historic Market Size by Type (2016-2021)
4.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Type (2022-2030)
5 Nausea And Vomiting Treatment Breakdown Data by Application (2016-2030)
5.1 Global Nausea And Vomiting Treatment Market Size by Application (2016-2021)
5.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Application (2022-2030)
6 North America
6.1 North America Nausea And Vomiting Treatment Market Size (2016-2021)
6.2 Nausea And Vomiting Treatment Key Players in North America (2016-2021)
6.3 North America Nausea And Vomiting Treatment Market Size by Type (2016-2021)
6.4 North America Nausea And Vomiting Treatment Market Size by Application (2016-2021)
7 Europe
7.1 Europe Nausea And Vomiting Treatment Market Size (2016-2021)
7.2 Nausea And Vomiting Treatment Key Players in Europe (2016-2021)
7.3 Europe Nausea And Vomiting Treatment Market Size by Type (2016-2021)
7.4 Europe Nausea And Vomiting Treatment Market Size by Application (2016-2021)
8 China
8.1 China Nausea And Vomiting Treatment Market Size (2016-2021)
8.2 Nausea And Vomiting Treatment Key Players in China (2016-2021)
8.3 China Nausea And Vomiting Treatment Market Size by Type (2016-2021)
8.4 China Nausea And Vomiting Treatment Market Size by Application (2016-2021)
9 Japan
9.1 Japan Nausea And Vomiting Treatment Market Size (2016-2021)
9.2 Nausea And Vomiting Treatment Key Players in Japan (2016-2021)
9.3 Japan Nausea And Vomiting Treatment Market Size by Type (2016-2021)
9.4 Japan Nausea And Vomiting Treatment Market Size by Application (2016-2021)
10 Key Players Profiles
10.1 Merck & Co. Inc.
10.1.1 Merck & Co. Inc. Company Details
10.1.2 Merck & Co. Inc. Business Overview and Its Total Revenue
10.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Introduction
10.1.4 Merck & Co. Inc. Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.1.5 Merck & Co. Inc. Recent Development
10.2 Helsinn Group
10.2.1 Helsinn Group Company Details
10.2.2 Helsinn Group Business Overview and Its Total Revenue
10.2.3 Helsinn Group Nausea And Vomiting Treatment Introduction
10.2.4 Helsinn Group Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.2.5 Helsinn Group Recent Development
10.3 Unimed Pharmaceuticals (AbbVie Inc.)
10.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Company Details
10.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Business Overview and Its Total Revenue
10.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Introduction
10.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Recent Development
10.4 Kyowa Kirin
10.4.1 Kyowa Kirin Company Details
10.4.2 Kyowa Kirin Business Overview and Its Total Revenue
10.4.3 Kyowa Kirin Nausea And Vomiting Treatment Introduction
10.4.4 Kyowa Kirin Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.4.5 Kyowa Kirin Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Details
10.5.2 Sanofi Business Overview and Its Total Revenue
10.5.3 Sanofi Nausea And Vomiting Treatment Introduction
10.5.4 Sanofi Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.5.5 Sanofi Recent Development
10.6 Qilu Pharma
10.6.1 Qilu Pharma Company Details
10.6.2 Qilu Pharma Business Overview and Its Total Revenue
10.6.3 Qilu Pharma Nausea And Vomiting Treatment Introduction
10.6.4 Qilu Pharma Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.6.5 Qilu Pharma Recent Development
10.7 Teva Pharmaceutical Industries Ltd.
10.7.1 Teva Pharmaceutical Industries Ltd. Company Details
10.7.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue
10.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Introduction
10.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.7.5 Teva Pharmaceutical Industries Ltd. Recent Development
10.8 Taiji group
10.8.1 Taiji group Company Details
10.8.2 Taiji group Business Overview and Its Total Revenue
10.8.3 Taiji group Nausea And Vomiting Treatment Introduction
10.8.4 Taiji group Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.8.5 Taiji group Recent Development
10.9 Novartis
10.9.1 Novartis Company Details
10.9.2 Novartis Business Overview and Its Total Revenue
10.9.3 Novartis Nausea And Vomiting Treatment Introduction
10.9.4 Novartis Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.9.5 Novartis Recent Development
10.10 Heron Therapeutics
10.10.1 Heron Therapeutics Company Details
10.10.2 Heron Therapeutics Business Overview and Its Total Revenue
10.10.3 Heron Therapeutics Nausea And Vomiting Treatment Introduction
10.10.4 Heron Therapeutics Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.10.5 Heron Therapeutics Recent Development
10.11 Atnahs Pharma UK Limited
10.11.1 Atnahs Pharma UK Limited Company Details
10.11.2 Atnahs Pharma UK Limited Business Overview and Its Total Revenue
10.11.3 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Introduction
10.11.4 Atnahs Pharma UK Limited Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.11.5 Atnahs Pharma UK Limited Recent Development
10.12 Mylan
10.12.1 Mylan Company Details
10.12.2 Mylan Business Overview and Its Total Revenue
10.12.3 Mylan Nausea And Vomiting Treatment Introduction
10.12.4 Mylan Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.12.5 Mylan Recent Development
10.13 Duchesnay
10.13.1 Duchesnay Company Details
10.13.2 Duchesnay Business Overview and Its Total Revenue
10.13.3 Duchesnay Nausea And Vomiting Treatment Introduction
10.13.4 Duchesnay Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.13.5 Duchesnay Recent Development
10.14 Tesaro
10.14.1 Tesaro Company Details
10.14.2 Tesaro Business Overview and Its Total Revenue
10.14.3 Tesaro Nausea And Vomiting Treatment Introduction
10.14.4 Tesaro Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.14.5 Tesaro Recent Development
11 Analyst's Viewpoints/Conclusions
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nausea And Vomiting Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Nausea And Vomiting Treatment Market Size Growth Rate by Type: 2022 VS 2030
1.4.2 Serotonin Receptor Antagonist
1.4.3 Neurokinin NK1 Receptor Antagonist
1.4.4 Other
1.5 Market by Application
1.5.1 Global Nausea And Vomiting Treatment Market Share by Application: 2022 VS 2030
1.5.2 CINV
1.5.3 PONV
1.5.4 Motion Sickness
1.5.5 Pregnancy
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Nausea And Vomiting Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Nausea And Vomiting Treatment Industry
1.6.1.1 Nausea And Vomiting Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Nausea And Vomiting Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Nausea And Vomiting Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Nausea And Vomiting Treatment Market Perspective (2016-2030)
2.2 Nausea And Vomiting Treatment Growth Trends by Regions
2.2.1 Nausea And Vomiting Treatment Market Size by Regions: 2016 VS 2022 VS 2030
2.2.2 Nausea And Vomiting Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Nausea And Vomiting Treatment Forecasted Market Size by Regions (2022-2030)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Nausea And Vomiting Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Nausea And Vomiting Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Nausea And Vomiting Treatment Players by Market Size
3.1.1 Global Top Nausea And Vomiting Treatment Players by Revenue (2016-2021)
3.1.2 Global Nausea And Vomiting Treatment Revenue Market Share by Players (2016-2021)
3.1.3 Global Nausea And Vomiting Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Nausea And Vomiting Treatment Market Concentration Ratio
3.2.1 Global Nausea And Vomiting Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Nausea And Vomiting Treatment Revenue in 2021
3.3 Nausea And Vomiting Treatment Key Players Head office and Area Served
3.4 Key Players Nausea And Vomiting Treatment Product Solution and Service
3.5 Date of Enter into Nausea And Vomiting Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2030)
4.1 Global Nausea And Vomiting Treatment Historic Market Size by Type (2016-2021)
4.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Type (2022-2030)
5 Nausea And Vomiting Treatment Breakdown Data by Application (2016-2030)
5.1 Global Nausea And Vomiting Treatment Market Size by Application (2016-2021)
5.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Application (2022-2030)
6 North America
6.1 North America Nausea And Vomiting Treatment Market Size (2016-2021)
6.2 Nausea And Vomiting Treatment Key Players in North America (2016-2021)
6.3 North America Nausea And Vomiting Treatment Market Size by Type (2016-2021)
6.4 North America Nausea And Vomiting Treatment Market Size by Application (2016-2021)
7 Europe
7.1 Europe Nausea And Vomiting Treatment Market Size (2016-2021)
7.2 Nausea And Vomiting Treatment Key Players in Europe (2016-2021)
7.3 Europe Nausea And Vomiting Treatment Market Size by Type (2016-2021)
7.4 Europe Nausea And Vomiting Treatment Market Size by Application (2016-2021)
8 China
8.1 China Nausea And Vomiting Treatment Market Size (2016-2021)
8.2 Nausea And Vomiting Treatment Key Players in China (2016-2021)
8.3 China Nausea And Vomiting Treatment Market Size by Type (2016-2021)
8.4 China Nausea And Vomiting Treatment Market Size by Application (2016-2021)
9 Japan
9.1 Japan Nausea And Vomiting Treatment Market Size (2016-2021)
9.2 Nausea And Vomiting Treatment Key Players in Japan (2016-2021)
9.3 Japan Nausea And Vomiting Treatment Market Size by Type (2016-2021)
9.4 Japan Nausea And Vomiting Treatment Market Size by Application (2016-2021)
10 Key Players Profiles
10.1 Merck & Co. Inc.
10.1.1 Merck & Co. Inc. Company Details
10.1.2 Merck & Co. Inc. Business Overview and Its Total Revenue
10.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Introduction
10.1.4 Merck & Co. Inc. Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.1.5 Merck & Co. Inc. Recent Development
10.2 Helsinn Group
10.2.1 Helsinn Group Company Details
10.2.2 Helsinn Group Business Overview and Its Total Revenue
10.2.3 Helsinn Group Nausea And Vomiting Treatment Introduction
10.2.4 Helsinn Group Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.2.5 Helsinn Group Recent Development
10.3 Unimed Pharmaceuticals (AbbVie Inc.)
10.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Company Details
10.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Business Overview and Its Total Revenue
10.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Introduction
10.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Recent Development
10.4 Kyowa Kirin
10.4.1 Kyowa Kirin Company Details
10.4.2 Kyowa Kirin Business Overview and Its Total Revenue
10.4.3 Kyowa Kirin Nausea And Vomiting Treatment Introduction
10.4.4 Kyowa Kirin Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.4.5 Kyowa Kirin Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Details
10.5.2 Sanofi Business Overview and Its Total Revenue
10.5.3 Sanofi Nausea And Vomiting Treatment Introduction
10.5.4 Sanofi Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.5.5 Sanofi Recent Development
10.6 Qilu Pharma
10.6.1 Qilu Pharma Company Details
10.6.2 Qilu Pharma Business Overview and Its Total Revenue
10.6.3 Qilu Pharma Nausea And Vomiting Treatment Introduction
10.6.4 Qilu Pharma Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.6.5 Qilu Pharma Recent Development
10.7 Teva Pharmaceutical Industries Ltd.
10.7.1 Teva Pharmaceutical Industries Ltd. Company Details
10.7.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue
10.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Introduction
10.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.7.5 Teva Pharmaceutical Industries Ltd. Recent Development
10.8 Taiji group
10.8.1 Taiji group Company Details
10.8.2 Taiji group Business Overview and Its Total Revenue
10.8.3 Taiji group Nausea And Vomiting Treatment Introduction
10.8.4 Taiji group Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.8.5 Taiji group Recent Development
10.9 Novartis
10.9.1 Novartis Company Details
10.9.2 Novartis Business Overview and Its Total Revenue
10.9.3 Novartis Nausea And Vomiting Treatment Introduction
10.9.4 Novartis Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.9.5 Novartis Recent Development
10.10 Heron Therapeutics
10.10.1 Heron Therapeutics Company Details
10.10.2 Heron Therapeutics Business Overview and Its Total Revenue
10.10.3 Heron Therapeutics Nausea And Vomiting Treatment Introduction
10.10.4 Heron Therapeutics Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.10.5 Heron Therapeutics Recent Development
10.11 Atnahs Pharma UK Limited
10.11.1 Atnahs Pharma UK Limited Company Details
10.11.2 Atnahs Pharma UK Limited Business Overview and Its Total Revenue
10.11.3 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Introduction
10.11.4 Atnahs Pharma UK Limited Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.11.5 Atnahs Pharma UK Limited Recent Development
10.12 Mylan
10.12.1 Mylan Company Details
10.12.2 Mylan Business Overview and Its Total Revenue
10.12.3 Mylan Nausea And Vomiting Treatment Introduction
10.12.4 Mylan Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.12.5 Mylan Recent Development
10.13 Duchesnay
10.13.1 Duchesnay Company Details
10.13.2 Duchesnay Business Overview and Its Total Revenue
10.13.3 Duchesnay Nausea And Vomiting Treatment Introduction
10.13.4 Duchesnay Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.13.5 Duchesnay Recent Development
10.14 Tesaro
10.14.1 Tesaro Company Details
10.14.2 Tesaro Business Overview and Its Total Revenue
10.14.3 Tesaro Nausea And Vomiting Treatment Introduction
10.14.4 Tesaro Revenue in Nausea And Vomiting Treatment Business (2016-2021)
10.14.5 Tesaro Recent Development
11 Analyst's Viewpoints/Conclusions
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Pricing
Select a license type that suits your business needs
Single User Access
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
Multi User Cost
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
Enterprise User Cost
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI